Influence of the technique and comorbidities in hypofractionated radiotherapy for prostate cancer.

Raquel CorreaI NavarroM LobatoA OteroI JerezJ M RicoI ZapataY LupiañezJ A MedinaD OlmosJ Gómez-Millán

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2019)

Hypofractionated radiotherapy for prostate cancer is an effective, well-tolerated treatment even for elderly patients with no associated comorbidity. Longer follow up is needed in order to report data on late toxicity.

Keyphrases

prostate cancer
radiation therapy
radical prostatectomy
early stage
locally advanced
radiation induced
oxidative stress
electronic health record
brain metastases
big data
small cell lung cancer
squamous cell carcinoma
machine learning
community dwelling
deep learning
combination therapy
smoking cessation